Phenylsulfamate

Phenylsulfamate

SCHEMBL3213804

NS(=O)(=O)Oc1ccccc1.[NaH]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CA2 P00918 13/20 0.95
CA9 Q16790 13/20 0.95
CA1 P00915 12/20 0.95
STS P08842 7/20 0.62
CA12 O43570 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylsulfamate SCHEMBL605969 0.97 CA2 (1.00) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL28069795 0.95 CA2 (0.95) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL4593104 0.95 CA2 (0.95) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL11845500 0.95 CA2 (0.95) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL28251303 0.95 CA2 (0.95) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL4592853 0.95 CA2 (0.95) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL26965424 0.85 CA2 (0.76) CA2CA9CA1STSCA12
SCHEMBL7263619 0.84 CA2 (1.00) CA2CA9CA1STSCA12
SCHEMBL2591595 0.82 CA2 (0.68) CA2CA9CA1STSCA12
SCHEMBL9451263 0.80 CA2 (1.00) CA2CA9CA1STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115784944-A Synthesis method of high-purity environment-friendly acid dye intermediate 宿迁虹光化学工业有限公司 2023-03-14 CN claimed
CN-110079284-A A kind of mud and drilling construction method for drilling construction 中国电力科学研究院有限公司 2019-08-02 CN claimed
CN-108774316-A Cationic polyarylether resin, seperation film and preparation method thereof 四川大学 2018-11-09 CN claimed
CN-105199423-B A kind of synthetic method of the violated pigment of cold labeling 上海化工研究院有限公司 2017-09-26 CN claimed
CN-107129176-A A kind of synthetic method of modified sulfamate water reducer 武汉理工大学 2017-09-05 CN claimed
CN-104830092-B Preparation method and applications of fire retardation dye 苏州大学 2017-01-11 CN claimed
EP-1919439-A2 PROCESS FOR BLEACHING KERATIN FIBERS The Procter and Gamble Company (US) 2008-05-14 EP claimed
EP-1919440-A2 AGENT FOR SIMULTANEOUS LIGHTENING AND COLORING OF KERATIN FIBRES CONTAINING A SULFAMATE BLEACH BOOSTER The Procter and Gamble Company (US) 2008-05-14 EP claimed
US-20070231283-A1 Process for bleaching keratin fibers PROCTER & GAMBLE COMPANY, THE 2007-10-04 US claimed
US-20070067925-A1 Agent for simultaneously lightening and coloring of fibers PROCTER & GAMBLE COMPANY, THE 2007-03-29 US claimed
WO-2007026327-A2 PROCESS FOR BLEACHING KERATIN FIBERS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO claimed
WO-2007026328-A2 AGENT FOR SIMULTANEOUS LIGHTENING AND COLORING OF KERATIN FIBRES CONTAINING A SULFAMATE BLEACH BOOSTER THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO claimed
EP-1759684-A1 Process for bleaching keratin fibers Wella Aktiengesellschaft (DE) 2007-03-07 EP claimed
EP-1759685-A1 Agent for simultaneous lightening and coloring of keratin fibres containing a sulfamate bleach booster Wella Aktiengesellschaft (DE) 2007-03-07 EP claimed
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2026-04-30 US disclosed
CN-119968127-A Animal food compositions with improved palatability and customizable properties and methods of making the same 玛氏公司 2025-05-09 CN disclosed
EP-4344552-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2024-04-03 EP disclosed
US-20050009831-A1 Pyrrolo[1,2-a]pyrazine-8-carboxamides are JNK inhibitors, useful as anticarcinogenic agents AVENTIS PHARMA S.A, (FR) 2005-01-13 US disclosed
EP-1436291-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS Aventis Pharma S.A. (FR) 2004-07-14 EP disclosed
WO-2003024967-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS AVENTIS PHARMA S.A. (FR) 2003-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070067925-A1 Agent for simultaneously lightening and coloring of fibers KIT, KRT18, H1-5 CA2 132/4885CA9 675/4885CA1 434/4885
US-20050009831-A1 Pyrrolo[1,2-a]pyrazine-8-carboxamides are JNK inhibitors, useful as anticarcinogenic agents CNKSR1, ROS1, NRAS CA2 1573/4885CA9 1913/4885CA1 2382/4885
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME PIGS, TAS2R13, CEL CA2 3201/4885CA9 1611/4885CA1 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.